LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Reset all filters
01 1LGM Pharma
02 1Gonane Pharma
03 1HRV Pharma
04 1Cerata Pharmaceuticals LLP
05 1Acebright India Pharma Private Limited
06 1Ajinomoto Company
07 1Alembic Pharmaceuticals Limited
08 1Alfa Chemistry
09 1Anax Laboratories
10 1Anhui Jingke Biotechnology
11 1Aspen Bio
12 1AstraZeneca
13 1BDR Lifesciences
14 1Biotechnica DWC
15 1Brawn Laboratories Ltd
16 1Cdymax
17 1Cipla
18 1Farmhispania
19 1Fujian South Pharmaceutical
20 1Guangzhou Tosun Pharmaceutical
21 1Hetero Drugs
22 1Jeil Pharmaceutical Co., Ltd
23 1Jiwan Pharmaceutical Technology Co., Ltd
24 1KOLON Life Science, Inc
25 1Kekule Pharma
26 1Kyongbo Pharmaceutical Co., Ltd
27 2MSN Laboratories
28 4Mac-Chem Products (India) Pvt.Ltd
29 1Natco Pharma
30 1Nishchem International Pvt. Ltd
31 1Parsian Pharamceutical
32 1Polaris AI Pharma
33 1Qilu Antibiotics Pharmaceutical Co., Ltd.
34 1Qilu Pharmaceutical
35 1Reyoung pharmaceutical
36 1SYNTHON Chemicals GmbH & Co. KG
37 1Sakar Healthcare
38 1ScinoPharm Taiwan Ltd
39 1Shandong Anhong Pharmaceutical
40 1Shouyuan Chemical
41 1Sichuan Xieli Pharmaceutical
42 1Suzhou Lixin Pharmaceutical
43 1Synthland
44 1Synthon Pharmaceuticals
45 1Vannsh Life Sciences
46 1Wisdom Pharmaceutical
47 1Yabao Pharmaceutical Group Co. Ltd
48 1Yangtze River Pharmaceutical Group
49 1Zhejiang Hisun Pharmaceutical
50 1Zhejiang Huahai Pharmaceutical
51 1Zhejiang Jiuzhou Pharmaceutical
Reset all filters
01 1Algeria
02 18China
03 1Germany
04 23India
05 1Iran
06 1Japan
07 1Netherlands
08 4South Korea
09 1Spain
10 1Taiwan
11 2U.S.A
12 1United Kingdom
Reset all filters
01 14Active
02 1Inactive
03 40Blank
01 1Expired
02 13Valid
03 1Withdrawn by Holder
04 40Blank
Reset all filters
01 1229MF10151
02 1229MF10197
03 1229MF10200
04 1230MF10026
05 1230MF10029
06 50Blank
Reset all filters
01 1WC-0041
02 1WC-0082
03 1WC-0138
04 1WC-014
05 1WC-0275
06 1WC-0349
07 1WC-0560
08 1WC-340n
09 47Blank
Reset all filters
01 11668-12-ND
02 11673-13-ND
03 1661-1-ND
04 1Number 6321-6-ND(1)
05 1Su3042-9-ND
06 1Su434-7-ND
07 1Su6321-6-ND
08 1Su6321-6-ND(3)
09 1Su6321-6-ND(4)
10 46Blank
Reset all filters
01 113612-0029
02 150923-1118
03 153104-7700
04 154245-1359
05 154893-0036
06 163850-8070
07 165344-0029
08 168554-0060
09 47Blank
01 55Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Gonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.
Cerata Pharmaceuticals LLP: WHO-GMP Certified Leading Manufacturer & Exporter of Steroid-Hormone & Peptide APIs From India.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28613
Submission : 2014-09-03
Status : Active
Type : II

GDUFA
DMF Review : Reviewed
Rev. Date : 2016-10-28
Pay. Date : 2016-06-15
DMF Number : 30518
Submission : 2016-04-28
Status : Active
Type : II
Certificate Number : CEP 2018-236 - Rev 02
Issue Date : 2025-06-05
Type : Chemical
Substance Number : 2866
Status : Valid
NDC Package Code : 65344-0029
Start Marketing Date : 2023-12-29
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40456
Submission : 2024-09-03
Status : Active
Type : II

GDUFA
DMF Review : Reviewed
Rev. Date : 2016-06-27
Pay. Date : 2015-11-19
DMF Number : 29797
Submission : 2015-11-17
Status : Active
Type : II

GDUFA
DMF Review : Reviewed
Rev. Date : 2016-07-05
Pay. Date : 2015-12-23
DMF Number : 26456
Submission : 2012-09-18
Status : Active
Type : II
Certificate Number : R0-CEP 2018-281 - Rev 00
Issue Date : 2020-02-24
Type : Chemical
Substance Number : 2866
Status : Expired

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27310
Submission : 2013-07-26
Status : Inactive
Type : II

13
PharmaCompass offers a list of Gefitinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Gefitinib manufacturer or Gefitinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Gefitinib manufacturer or Gefitinib supplier.
A Gefitinib - Iressa manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Gefitinib - Iressa, including repackagers and relabelers. The FDA regulates Gefitinib - Iressa manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Gefitinib - Iressa API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Gefitinib - Iressa manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Gefitinib - Iressa supplier is an individual or a company that provides Gefitinib - Iressa active pharmaceutical ingredient (API) or Gefitinib - Iressa finished formulations upon request. The Gefitinib - Iressa suppliers may include Gefitinib - Iressa API manufacturers, exporters, distributors and traders.
click here to find a list of Gefitinib - Iressa suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
We have 51 companies offering Gefitinib - Iressa
Get in contact with the supplier of your choice: